CAS RN: 4363-93-3
4-Quinolinecarboxaldehyde
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20250829
1g / 5g / 25g
Confirm by inquiry
Shanghai, Shandong Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 4363-93-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
25g
≥95%
0
Out of Stock
Hong Kong
Inquiry
4363-93-3 / quinoline-4-carbaldehyde
Standard CAS: 4363-93-3
Multi CAS: Yes
Basic Information
copy
CAS
4363-93-3 copy
Multi CAS
Yes copy
Molecular Formula
C10H7NO copy
Molecular Weight
157.170000 copy
Exact Mass
157.052764 copy
InChI
InChI=1S/C10H7NO/c12-7-8-5-6-11-10-4-2-1-3-9(8)10/h1-7H copy
InChIKey
MGCGJBXTNWUHQE-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
12 copy
Aromatic heavy atom count
10 copy
Rotatable bonds
1 copy
H-bond acceptors
2 copy
Molar refractivity
47.13 copy
TPSA
29.96 copy
LogP / Solubility
WLOGP
2.05 copy
MLOGP
1.8 copy
XLogP3
0.4 copy
Consensus LogP
1.42 copy
Log S (ESOL)
-2.65 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.33 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.5 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.23 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy